"Washington Health System Radiation Oncology is a Cancer Treatment Center located in Washington.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Washington Hospital Radiation Oncology conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 33 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 30 clinical trials were completed. i.e. 272.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Washington Hospital Radiation Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "NRG Oncology" with 8 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Washington Hospital Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 41 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Washington Hospital Radiation Oncology" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IIIA Breast Cancer" (6 trials), "Invasive Breast Carcinoma" (5 trials) and "Stage II Breast Cancer" (5 trials). Many other conditions were trialed in "UPMC Washington Hospital Radiation Oncology" in a lesser frequency.

Most popular intervention types in "UPMC Washington Hospital Radiation Oncology" are "Drug" (59 trials), "Other" (53 trials), "Biological" (29 trials), "Radiation" (26 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (17 trials), "Cisplatin" (14 trials), "Docetaxel" (12 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Washington Hospital Radiation Oncology" are 58 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Washington Hospital Radiation Oncology". undefined are not yet recruiting, 17 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in UPMC Washington Hospital Radiation Oncology, 4 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Washington Hospital Radiation Oncology, 0 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".